K Number
K123920
Device Name
SYNGO.VIA
Date Cleared
2013-01-18

(29 days)

Product Code
Regulation Number
892.2050
Reference & Predicate Devices
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

syngo.via is a software solution intended to be used for viewing, manipulation, communication, and storage of medical images. It can be used as a stand-alone device or together with a variety of cleared and unmodified syngo based software options. syngo.via supports interpretation and evaluation of examinations within healthcare institutions, for example, in Radiology, Nuclear Medicine and Cardiology environments. The system is not intended for the displaying of digital mammography images for diagnosis in the U.S.

Device Description

syngo.via is a software solution intended to be used for viewing, manipulation, communication, and storage of medical images. It can be used as a stand-alone device or together with a variety of cleared and unmodified syngo based software options. syngo.via supports interpretation and evaluation of examinations within healthcare institutions, for example, in Radiology, Nuclear Medicine and Cardiology environments. The system is not intended for the displaying of digital mammography images for diagnosis in the U.S. The system is a software only medical device. It defines minimum requirements to the hardware it runs on. The hardware itself is not seen as a medical device and not in the scope of this 510(k) submission. It supports the physician in diagnosis and treatment planning. syngo.via also supports storage of Structured DICOM Reports. In a comprehensive imaging suite syngo.via integrates Radiology Information Systems (RIS) to enable customer specific workflows. The predicate device, syngo.via allows for the use of a variety of advanced applications (clinical applications) These applications are medical devices on their own rights and filed separately. They are not part of this 510(k) submission and not part of the syngo.via medical device. syngo.via has a universal component called generic reader application which is part of this medical device and it allows no newly introduced imaging and post processing algorithms compared to the above mentioned predicate devices. syngo.via is based on Windows. Due to special customer requirements and the clinical focus syngo.via can be configured in the same way as the predicate device with different combinations of syngo- or Windows based software options and clinical applications which are intended to assist the physician in diagnosis and/or treatment planning. This includes commercially available post-processing software packages.

AI/ML Overview

Here's an analysis of the provided 510(k) summary regarding acceptance criteria and supporting studies:

This 510(k) pertains to "syngo.via," a PACS system. Based on the document, this 510(k) is for enhanced functionalities of syngo.via, making it an update or extension of a previously cleared device (K123375). The key here is that it's not a new AI algorithm designed for a
specific diagnostic task with associated performance metrics. Instead, it seems to be primarily a software platform update that integrates functionalities already present in other cleared Siemens products.

Therefore, the typical structure for reporting AI/CADe/CADx device performance (sensitivity, specificity, AUROC, etc.) involving a test set, ground truth, and expert readers is not applicable in this submission. The "acceptance criteria" discussed are likely related to software verification and validation, adherence to standards, and demonstrating substantial equivalence to existing devices with similar functionalities.


1. Table of Acceptance Criteria and Reported Device Performance

As mentioned above, this 510(k) is for an enhanced PACS system and does not present specific diagnostic performance metrics. The "performance" is primarily demonstrated through compliance with standards and equivalence to predicate devices. There are no explicit quantitative acceptance criteria for diagnostic performance in terms of sensitivity, specificity, etc., as it's not a new diagnostic algorithm.

The "performance" described is in terms of:

  • Software Functionality: Viewing, manipulation, communication, and storage of medical images.
  • Integration: HL7-/DICOM-compatible RIS workflow.
  • Technological Characteristics: Runs on Windows OS, supports DICOM images, image data compression (lossless and lossy).
  • Imaging Algorithms (inherited/similar to predicates): MPR, MIP, MinIP, VRT, SSD, Digitally Reconstructed Radiograph, Editor functionality, Registration, Region Growing, Quantitative measurements.
  • Automatic Spine Labeling (inherited/similar to predicates): Anatomy Labeling of Vertebra bodies, automatically suggested labels with manual override.
Acceptance Criteria CategoryReported Device Performance/Characteristics
Intended Use Fulfillmentsyngo.via is intended for viewing, manipulation, communication, and storage of medical images. It supports interpretation and evaluation of examinations within healthcare institutions.
Technological CharacteristicsSoftware-only system (runs on specified IT hardware). Backend: Windows 2008. Client: Windows XP, Vista, 7. Supports DICOM formatted images and objects. Image data compression: Lossless (factor 2-3), lossy (higher rate). Receives/decompresses JPEG2000. Incorporates imaging algorithms like MPR, MIP, MinIP, VRT, SSD, DRR, Editing, Registration, Region Growing, Quantitative measurements (distance, angle). Supports Automatic Spine Labeling: Anatomy Labeling of Vertebra bodies, with automatically suggested labels and manual override. Supports multi-time point registration and user verification.
IntegrationWorkflow Management with HL7-/DICOM-compatible RIS (IHE Year 5).
Safety and Effectiveness ControlsSoftware verification and validation (Unit, Integration, System Test Levels) performed according to: DICOM Standard [2011], ISO/IEC 15444-1:2005+TC 1:2007, ISO/IEC 10918-1:1994 + TC 1:2005, HL7 [2006], IEC 62304:2006, IEC 62366:2007, ISO 14971:2007, IEC 60601-1-4:2000. Risk analysis performed to identify and control potential hazards. Device labeling contains instructions, cautions, and warnings. Adheres to recognized industry practices and standards. Supports quality assurance methods (e.g., SMPTE, HIPAA). Major software self-tests/checks are performed. Device is a post-processing software with no capability to control connected modalities.
Substantial EquivalenceDemonstrated substantial equivalence to several Siemens predicate devices (syngo.via K123375, SOMATOM Definition Edge CT System K120579, syngo.CT Vascular Analysis K112020, Software syngo MR D13A K121434, syngo TrueD K101749) by incorporating similar functionalities without introducing new significant safety risks.

2. Sample size used for the test set and the data provenance

The document does not describe a "test set" in the context of diagnostic performance evaluation (e.g., a set of medical images used to evaluate an algorithm's diagnostic accuracy). The testing performed was software verification and validation testing at Unit, Integration, and System levels, as per IEC 62304. This type of testing uses various software inputs and configurations to ensure functional correctness, rather than a diagnostic image dataset. No specific sample size of images or data provenance (country, retrospective/prospective) is provided because it's not relevant for this type of submission.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

Not applicable. There was no diagnostic "test set" requiring expert ground truth for diagnostic accuracy evaluation.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

Not applicable. There was no diagnostic "test set" requiring expert ground truth or adjudication.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This 510(k) does not present an MRMC study comparing human reader performance with and without AI assistance, as it is a PACS system enhancement, not a new AI-powered diagnostic tool.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

Not applicable. This is not a standalone diagnostic algorithm. syngo.via is a platform for viewing, manipulation, communication, and storage of medical images, intended to "support the physician in diagnosis and treatment planning." The functionalities described (like automatic spine labeling) are features within this broader platform, and their performance is indicated as being similar to those from previously cleared predicate devices.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

Not applicable. As there was no diagnostic test set in the traditional sense, there was no ground truth for diagnostic accuracy established through expert consensus, pathology, or outcomes data. The "ground truth" for the software's functional performance would be defined by the software requirements and design specifications, verified through testing procedures.

8. The sample size for the training set

Not applicable. This 510(k) does not describe a new AI algorithm that requires a training set. The enhanced functionalities are stated to have "similar technological characteristics as the predicate device" and incorporate "imaging and post processing algorithms compared to the above mentioned predicate devices." This implies that any underlying algorithms for features like "Automatic Spine Labeling" are either existing, well-established, or derived from components previously cleared, rather than newly developed and trained models.

9. How the ground truth for the training set was established

Not applicable, as there is no mention of a training set for a new algorithm in this 510(k) submission.

{0}------------------------------------------------

K123920

510(k) Summary

This summary of 510(k) safety and effectiveness information is being I his summary of STORIS, with the requirements of SMDA 1990 and 21 CFR §807.92.

I. GENERAL INFORMATION

Contact Person:

Establishment: .

Address: .

.

Siemens AG, Medical Solutions Henkestrasse 127 D-91052 Erlangen Germany

  • Registration Number: 3002808157 .
    Sabine Schroedel Regulatory Affairs Manager Telephone: +49 (9131) 84-8285 +49 (9131) 84-2792 Fax:

Device Name and Classification:

Trade Name:syngo.via
Classification Name:Picture Archiving and CommunicationsSystem
Classification Panel:Radiology
CFR Section:21 CFR §892.2050
Device Class:Class II
Product Code:LLZ

{1}------------------------------------------------

II. SAFETY AND EFFECTIVENESS INFORMATION SUPPORTING THE SUB-STANTIAL EQUIVALENCE DETERMINATION

Device Description and Intended Use:

This premarket notification covers Siemens' enhanced PACS system svngo.via.

syngo.via is a software solution intended to be used for viewing, manipulation, communication, and storage of medical images. It can be used as a stand-alone device or together with a variety of cleared and unmodified syngo based software options. syngo.via supports interpretation and evaluation of examinations within healthcare institutions, for example, in Radiology, Nuclear Medicine and Cardiology environments. The system is not intended for the displaying of digital mammography images for diagnosis in the U.S.

The system is a software only medical device. It defines minimum rea no byeten is to the hardware it runs on. The hardware itself is not seen as a medical device and not in the scope of this 510(k) submission.

It supports the physician in diagnosis and treatment planning. syngo.via also supports storage of Structured DICOM Reports.

In a comprehensive imaging suite syngo.via integrates Radiology Information Systems (RIS) to enable customer specific workflows.

The predicate device, syngo.via allows for the use of a variety of advanced applications (clinical applications) These applications are medical devices on their own rights and filed separately. They are not part of this 510(k) submission and not part of the syngo.via medical device. syngo.via has a universal component called generic reader application which is part of this medical device and it allows no newly introduced imaging and post processing algorithms compared to the above mentioned predicate devices.

syngo.via is based on Windows. Due to special customer requirements and the clinical focus syngo.via can be configured in the same way as the predicate device with different combinations of syngo- or Windows based software options and clinical applications which are intended to assist the physician in diagnosis and/or treatment planning. This includes commercially available post-processing software packages.

syngo.via Data Management

... ensures all authorized personnel fast and continuous access to radiological data. It's main functionality ranges from availability of images with regard to data security, open interfaces, storage media and central system administration, to provide a flexible storage hierarchy.

{2}------------------------------------------------

Integration:

The Workflow Management enables by integration of any HL7- / DICOMcompatible RIS (IHE Year 5) to the syngo product family a consistent workflow - from patient registration to requirement scheduling to a personal work list and supports therefore reporting, documentation or administrative tasks.

Technological Characteristics:

syngo.via is a "software only"-system, which will be delivered on CD-ROM / DVD to be installed on common IT hardware. This hardware has to fulfil the defined requirements.

The backend communication and storage solution is based on Windows 2008 operating system. The client machines are based on Windows XP, Windows Vista and Windows 7. Any hardware platform, which complies to the specified minimum hardware and software requirements and with successful installation verification and validation activities can be supported.

The herewith described syngo.via supports DICOM formatted images and objects.

The syngo via will be marketed as a software only solution for the enduser (with recommended hardware requirements). Any special needs such as integration in a specific environment and updates / upgrades will be covered by individual service contract and fulfilled by special trained service technicians.

syngo.via will be used for viewing, manipulation, communication, and storage of medical images. The predicate device syngo.via is also capable of viewing, manipulation, communication, and storage of medical images.

The difference between the syngo.via and the predicate device syngo.via are to give the subject device greater capabilities than the predicate device, syngo, via has similar technological characteristics as the predicate device and is similar to the functionalities of the predicate device.

{3}------------------------------------------------

FunctionalityPrincipal DevicePredicate DevicePredicate DevicePredicate DevicePredicate DevicePredicate Devicetransfer protocol for use inside syngo@.viatransfer protocol for use inside syngo@.via
syngo.viasyngo.via VA20ASOMATOM Definition Edge CT Systemsyngo.CT Vascular AnalysisSoftware syngo MR D13A for MAGNETRON systems.syngo TrueDImage data compressionLossless compression with compression factor 2 to 3 and lossy compression with higher compression rate. Receive and decompress of JPEG2000 compressed images.Lossless compression with compression factor 2 to 3 and lossy compression with higher compression rate. Receive and decompress of JPEG2000 compressed images.None
FDA ClearanceK123375K120579K112020K121434K101749Imaging AlgorithmsMPR; MIP; MinIP; VRT; SSD; Digitally Reconstructed Radiograph; Editor functionality / Clip-Box / ClipPlane; Registration; Region Growing; Quantitative measurements such as distance; angle.MPR; MIP; MinIP; VRT; SSD; Digitally Reconstructed Radiograph; Editor functionality / Clip-Box / ClipPlane; Registration; Region Growing; Quantitative measurements such as distance; angle.N/A
ManufacturerSiemens AG Medical SolutionsSiemens AG Medical SolutionsSiemens AG Medical SolutionsSiemens AG Medical SolutionsSiemens AG Medical SolutionsSiemens AG Medical SolutionsHardware/OSClient: PC with Windows XP, Windows Vista, Windows 7Client: PC with Windows XP, Windows Vista, Windows 7PC with Windows XP Professional, Celsius Hardware
Intended Usesyngo.via is a software solution intended to be used for viewing, manipulation, communication, and storage of medical images.It can be used as a stand-alone device or together with a variety of cleared and unmodified syngo based software options.syngo.via supportssyngo.via is a software solution intended to be used for viewing, manipulation, communication, and storage of medical images.It can be used as a stand-alone device or together with a variety of cleared and unmodified syngo based software options.syngo.via supportsThe Siemens SOMATOM Definition Edge (Project P46F) systems are intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from either the same axial plane taken at different angles or spiral planes* taken at different angles.(*spiral planes: the axialsyngo.CT Vascular Analysis is an image analysis software package for evaluating enhancedCT images.Combining digital image processing and visualization tools (multiplanar reconstruction (MPR) thin/thick, maximum intensity projection (MIP) thin/thick, inverted MIPThe MAGNETOM systems described above are indicated for use as magnetic resonance diagnostic devices (MRDD) that produce transverse, sagittal, coronal and oblique cross sectional images, spectroscopic images and/or spectra, and that display the internal structure and/or function of the head, body, orsyngo TrueD is a medical diagnostic application for viewing, manipulation, 3D-visualization and comparison of medical images from multiple imaging modalities and/or multiple time-points.The application supports functional data, such as PET or SPECT as well as anatomical datasets, such as CT or MR.Not Applicable - not a stand-alone medical device.
interpretation andevaluation of exami-nations withinhealthcare institu-tions, for example,in Radiology, Nu-clear Medicine andCardiology envi-ronments.The system is notapproved in the U.S.for the display-ing of digital mammography images fordiagnosis.interpretation andevaluation of exami-nations withinhealthcare institu-tions, for example,in Radiology, Nu-clear Medicine andCardiology envi-ronments.The system is notapproved in the U.S.for the display-ing of digital mammography images fordiagnosis.planes resulted fromthe continuous rota-tion of detectors andx-ray tube, and thesimultaneous transla-tion of the patient.)thin/thick, volumerendering technique(VRT), curved pla-nar reformation(CPR), processingtools (bone removal(based both on singleenergy and DualEnergy), table re-moval) and evalua-tion tools(vessel centerlinecalculation, lumencalculation, stenosiscalculation) and re-porting tools (lesionlocation, lesion char-acteristics and keyimages), the soft-ware package is de-signed tosupport the physi-cian in confirmingthe presence or ab-sence of physician-identified lesions inblood vessels andevaluation, docu-mentation and fol-low-up of any suchextremities.Other physical pa-rameters derivedfrom the imagesand/or spectra mayalso be produced.Depending on theregion of interest,contrast agents maybe used. These im-ages and/or spectraand the physical pa-rameters derivedfrom the imagesand/or spectra, wheninterpreted by atrained physician,yield informationthat may assist indiagnosis.The MAGNETOMsystems describedabove may also beused for imagingduring interventionalprocedures whenperformed with MRcompatible devicesThe images can beviewed in a numberof output formatsincluding MIP andvolume rendering.syngo TrueD enablesvisualization of in-formation that wouldotherwise have to bevisually compareddisjointedly. syngoTrueD provides ana-lytical tools to helpthe user assess, anddocument changes inmorphological orfunctional activity atdiagnostic and ther-apy follow-up ex-aminations. syngoTrueD is designed tosupport the on-cological workflowby helping the userto confirm the ab-sence or presence oflesions, includingevaluation, quantifi-cation, follow-upand documentationMinimum Requirements - Intel Pentium IV Processor, 2.00 GHz, MS Win-
Image communicationStandard network protocols like TCP/IP and standard communication protocol DICOM. Additional fast imageStandard network protocols like TCP/IP and standard communication protocol DICOM.Standard network protocols like TCP/IP and standard communication protocol DICOM.PC with Windows XP Professional, Celsius Hardware
lesion.These visualization/processing/evaluation tools allow for characterization of vascular lesions and lesion size over time, helping the physician to assess the changes in their growth. It is also designed to help the physician classify conspicuous regions of tissue.Not Applicable – not a stand-alone medical device.such as in-room display and MR-safe biopsy needlesof any such lesions.The application allows to store and export volume of interest (VOI) structures in DICOM RT format for use in radiation therapy planning systems. syngo TrueD allows visualization and analysis of respiratory gated studies to support accurate delineation of the target or treatment volume over a defined phase of the respiratory cycle and thus provide information for radiation therapy planning.Standard network protocols like TCP/IP and standard communication protocol DICOM.NoneNoneNone
N/AN/AN/A

Predicate Device Comparison Table

مز

. Page K7

November 30, 2012

510(k) for syngo®.via enhanced

{4}------------------------------------------------

.

.

Page K8


November 30, 2012


:

·

{5}------------------------------------------------

i

Page K9

{6}------------------------------------------------

Page K10

November 30, 2012


{7}------------------------------------------------

Server WindowsServer 2008 R2(HW is not understood as part of themedical device, butneeds to comply tothe minimum requirements as specified by syngo.via)Server WindowsServer 2008 R2(HW is not understood as part of themedical device, butneeds to comply tothe minimum requirements as specified by syngo.via)Software packageattached to ModalityScanner (CT)dows XP SP1 orlaterSoftware packageattached to ModalityScanner (MR)
Major Safety Characteristicssubject device is a post-processing software package with no implementedcapability to control theconnected modalities;support of quality assurance methods such asSMPTE; HIPAA; majorsoftware self tests /checks.subject device is a post-processing software package with no implementedcapability to control theconnected modalities;support of quality assurance methods such asSMPTE; HIPAA; majorsoftware self tests /checks.subject device is a post-processing software package with no implementedcapability to control theconnected modalities;support of quality assurance methods such asSMPTE; HIPAA; majorsoftware self tests /checks.subject device is a post-processing software package with no implementedcapability to control theconnected modalities;support of quality assurance methods such asSMPTE; HIPAA; majorsoftware self tests /checks.
Automatic SpineLabelingAnatomy LabelingNot applicableAnatomy labels areautomatically suggested, with manualoverride possible.Anatomy labels areautomatically suggested, with manualoverride possible.N/A
Anatomy LabelledVertebra bodiesNot applicableVertebra bodies anddiscsCoronary vessels.Vertebra bodies anddiscsN/A
Labeling WorkflowAutomatically suggested labels areNot applicableAutomatically suggested labels areAutomatically suggested labels areAutomatically suggested labels areN/A

Page K11

November 30, 2012

510(k) for syngo®.via enhanced

{8}------------------------------------------------

N/AN/A
isplayed by unching the wor ow function.iditing of labels is orovided to oversis he automatically he automatically uggested labels.st verification step provided where there there there the according the accounting accounts the accountry habesting.Supports manual editing of labelling of labelling of thebels.
diting of labels is is overrist rovided to overrist te automatically Iggested labels.splayed by unching the wor ow function.N/Aupports manual diting of labels. Acluding instelling instelling including including delection of delection of delection of delection of delection of delection of delection de
splayed by lunching the wor low function.diting of labels i rovided to oversions in the supportunities andupports manual diting of lautoma liting of lautoma sertion and del
applicablNotNot applicable
diting of labels is is rovided to overrise ne automatics ally uggested labels.isplayed by lunching the wor ow function.ានupports manual nd semi-automal ditimg of lautomas, and semi-aman arough instruments, and sensions, arough instrugues nd delletinon nd deletinon of t
abeling Confirmtionbeling Edit

.

.

Page K12

November 30, 2012

510(k) for syngo®.via enhanced

{9}------------------------------------------------

Menu of spine labels names provided.Menu of spine labels names provided.Menu of vessel labels names provided.Menu of spine labels names provided.
Cross-sectional imaging (CT, MR)Not applicableCross-sectional imaging (CT)Cross-sectional imaging (CT)Cross-sectional imaging (MR)N/A
Landmark-based alignmentNot applicableN/AN/AN/ALandmark-based alignment
Across multiple time-pointsNot applicableN/AN/AN/AAcross multiple time-points
Cross-sectional imaging (CT, MR)Not applicableN/AN/AN/ACross-sectional imaging (CT)
Registration verification by userNot applicableN/AN/AN/ARegistration verification by user
Manual registration adjustments madeNot applicableN/AN/AN/AManual registration adjustments made through visual tools

:

510(k) for syngo®.via enhanced

Page K13

November 30, 2022

{10}------------------------------------------------

Page K14 November 30, 2012 through visual tools : 510(k) for syngo®.via enhanced

for synapse.org via SIA enhancement


{11}------------------------------------------------

Summary of Non-Clinical Tests:

Summary of Non-Clinical Tests:

The software verification and validation (Unit Test Level, Integration Test Level and System Test Level) was performed for all newly developend components and the complete system according to the following standards:

  • DICOM Standard [2011]
  • ISO/IEC 15444-1:2005+TC 1:2007
  • ISO/IEC 10918-1:1994 + TC 1:2005
  • HL7 [2006]
  • IEC 62304:2006
  • IEC 62366:2007
  • ISO 14971:2007
  • IEC 60601-1-4:2000

General Safety and Effectiveness Concerns: .

The device labeling contains instructions for use and any necessary cautions and warning, to provide for safe and effective use of the device.

Risk management is ensured via a risk analysis, which is used to identify potential hazards. These potential hazards are controlled via software development, verification and validation testing. To minimize hazards, Siemens adheres to recognized and established industry practice and standards.

syngo.via conforms to the applicable FDA recognized and international IEC, ISO, and NEMA standards with regards to performance and safety as recommended by the respective FDA Guidance Document.

{12}------------------------------------------------

Substantial Equivalence: .

The syngo.via extended functionalities addressed in this premarket notification, is substantially equivalent to the following commercially available devices:

Manu-facturerPredicate Device NameFDA ClearanceNumber
Siemenssyngo.viaK123375
SiemensSOMATOM Definition Edge CT SystemK120579
Siemenssyngo.CT Vascular AnalysisK112020
SiemensSoftware syngo MR D13A for MAGNETOMsystems Aera/Skyra/Avanto/VerioK121434
Siemenssyngo TrueDK101749

The added capabilities to syngo.via described in this 510(k) has similar functionalities that can be found in the devices listed above

In summary, Siemens is of the opinion that syngo.via does not introduce any new significant potential safety risks and is substantially equivalent to and performs as well as the predicate devices.

{13}------------------------------------------------

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-002

January 18, 2013

Siemens AG Healthcare SY % Mr. Norbert Stuiber Responsible Third Party Official TUV America Inc. 1775 Old Highway 8 NW NEW BRIGHTON MN 55112

Re: K123920

Trade/Device Name: syngo®:via Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: December 14, 2012 Received: December 20, 2012

Dear. Mr. Stuiber:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The I ou may, alore, many interest of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set

{14}------------------------------------------------

Page 2-Mr. Stuiber

forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic form in the quand of ovisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please 11 you desire spoonis advice tory DA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please the Center for Devices and Racioney by reference to premarket notification" (21CFR Part note the regulations regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Tou may of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

Sean M. Boyd -S for

Janine M. Morris Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

{15}------------------------------------------------

INDICATIONS FOR USE

510(k) Number (if known):____________________________________________________________________________________________________________________________________________________
Device Name:syngo ®. via

Indications For Use:

syngo.via is a software solution intended to be used for viewing, manipulation, communication, and storage of medical images.

and storage of medical mages.
It can be used as a stand-alone device or together with a variety of cleared and unmodified syngo based software options.

syngo.via supports interpretation and evaluation of examinations within healthcare institutions, for syngo. Na supports intorprotation and Cardiology environments.

The system is not intended for the displaying of digital mammography images for diagnosis in the ા કર

X Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (Part 21 CFR 801 Subpart C)

(Please do not write below this line - continue on another page if needed)

AND / OR

_____________________________________________________________________________________________________________________________________________________________________________ Concurrence of the CDRH, Office of In Vitro Diagnostic Devices (OIVD)

si. 7

Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety

510(k) K123920

Page 1 of __

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).